US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 1.330
  • 0.0000.00%
Close Feb 14 16:00 ET
54.64MMarket Cap-4.59P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-12.68%2.41M
-14.82%2.17M
-29.49%8.31M
-46.26%1.34M
-41.89%1.66M
-27.61%2.76M
-2.62%2.54M
72.50%11.78M
7.26%2.49M
52.37%2.86M
Selling and administrative expenses
-19.45%1.37M
-13.84%1.1M
-23.02%4.76M
-18.99%872.66K
-48.39%915.91K
-12.63%1.7M
-8.27%1.27M
59.79%6.18M
-10.78%1.08M
84.04%1.77M
-General and administrative expense
-19.45%1.37M
-13.84%1.1M
-23.02%4.76M
-18.99%872.66K
-48.39%915.91K
-12.63%1.7M
-8.27%1.27M
59.79%6.18M
-10.78%1.08M
84.04%1.77M
Research and development costs
14.86%1.22M
3.51%1.31M
-36.63%3.55M
-67.00%467.71K
-31.30%748.34K
-43.17%1.06M
3.80%1.27M
89.10%5.6M
26.74%1.42M
19.01%1.09M
Other operating expenses
---177.7K
---245.36K
----
----
----
----
----
----
----
----
Operating profit
12.68%-2.41M
14.82%-2.17M
29.49%-8.31M
46.26%-1.34M
41.89%-1.66M
27.61%-2.76M
2.62%-2.54M
-72.50%-11.78M
-7.26%-2.49M
-52.37%-2.86M
Net non-operating interest income expense
-220.48%-52.63K
-161.04%-33.69K
5.83%97.79K
-158,066.67%-9.48K
-89.40%8.39K
395.51%43.68K
55.2K
1,160.32%92.41K
6
79.15K
Non-operating interest income
-90.64%7.07K
-52.89%26.01K
169.48%249.02K
836,866.67%50.22K
-13.98%68.08K
756.65%75.52K
--55.2K
1,160.32%92.41K
--6
--79.15K
Non-operating interest expense
87.50%59.7K
--59.7K
--151.23K
--59.7K
--59.7K
--31.84K
--0
--0
--0
--0
Other net income (expense)
107.91%47
-103.70%-283
122.51%9.26K
89.64%-124
117.74%2.32K
97.38%-594
3,511.79%7.66K
-2,215.48%-41.15K
73.92%-1.2K
-514.91%-13.08K
Other non- operating income (expenses)
107.91%47
-103.70%-283
122.51%9.26K
89.64%-124
117.74%2.32K
97.38%-594
3,511.79%7.66K
-2,215.48%-41.15K
73.92%-1.2K
-514.91%-13.08K
Income before tax
9.36%-2.46M
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
Income tax
Net income
9.36%-2.46M
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
Net income continuous Operations
9.36%-2.46M
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
Minority interest income
Net income attributable to the parent company
9.36%-2.46M
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.36%-2.46M
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
Basic earnings per share
18.18%-0.09
20.00%-0.08
31.91%-0.32
50.00%-0.05
45.45%-0.06
26.67%-0.11
9.09%-0.1
-62.07%-0.47
0.00%-0.1
-37.50%-0.11
Diluted earnings per share
18.18%-0.09
20.00%-0.08
31.91%-0.32
50.00%-0.05
45.45%-0.06
26.67%-0.11
9.09%-0.1
-62.07%-0.47
0.00%-0.1
-37.50%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -12.68%2.41M-14.82%2.17M-29.49%8.31M-46.26%1.34M-41.89%1.66M-27.61%2.76M-2.62%2.54M72.50%11.78M7.26%2.49M52.37%2.86M
Selling and administrative expenses -19.45%1.37M-13.84%1.1M-23.02%4.76M-18.99%872.66K-48.39%915.91K-12.63%1.7M-8.27%1.27M59.79%6.18M-10.78%1.08M84.04%1.77M
-General and administrative expense -19.45%1.37M-13.84%1.1M-23.02%4.76M-18.99%872.66K-48.39%915.91K-12.63%1.7M-8.27%1.27M59.79%6.18M-10.78%1.08M84.04%1.77M
Research and development costs 14.86%1.22M3.51%1.31M-36.63%3.55M-67.00%467.71K-31.30%748.34K-43.17%1.06M3.80%1.27M89.10%5.6M26.74%1.42M19.01%1.09M
Other operating expenses ---177.7K---245.36K--------------------------------
Operating profit 12.68%-2.41M14.82%-2.17M29.49%-8.31M46.26%-1.34M41.89%-1.66M27.61%-2.76M2.62%-2.54M-72.50%-11.78M-7.26%-2.49M-52.37%-2.86M
Net non-operating interest income expense -220.48%-52.63K-161.04%-33.69K5.83%97.79K-158,066.67%-9.48K-89.40%8.39K395.51%43.68K55.2K1,160.32%92.41K679.15K
Non-operating interest income -90.64%7.07K-52.89%26.01K169.48%249.02K836,866.67%50.22K-13.98%68.08K756.65%75.52K--55.2K1,160.32%92.41K--6--79.15K
Non-operating interest expense 87.50%59.7K--59.7K--151.23K--59.7K--59.7K--31.84K--0--0--0--0
Other net income (expense) 107.91%47-103.70%-283122.51%9.26K89.64%-124117.74%2.32K97.38%-5943,511.79%7.66K-2,215.48%-41.15K73.92%-1.2K-514.91%-13.08K
Other non- operating income (expenses) 107.91%47-103.70%-283122.51%9.26K89.64%-124117.74%2.32K97.38%-5943,511.79%7.66K-2,215.48%-41.15K73.92%-1.2K-514.91%-13.08K
Income before tax 9.36%-2.46M11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M
Income tax
Net income 9.36%-2.46M11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M
Net income continuous Operations 9.36%-2.46M11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M
Minority interest income
Net income attributable to the parent company 9.36%-2.46M11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.36%-2.46M11.29%-2.2M30.09%-8.2M45.91%-1.35M40.90%-1.65M28.99%-2.72M5.02%-2.48M-71.89%-11.73M-7.44%-2.5M-49.11%-2.8M
Basic earnings per share 18.18%-0.0920.00%-0.0831.91%-0.3250.00%-0.0545.45%-0.0626.67%-0.119.09%-0.1-62.07%-0.470.00%-0.1-37.50%-0.11
Diluted earnings per share 18.18%-0.0920.00%-0.0831.91%-0.3250.00%-0.0545.45%-0.0626.67%-0.119.09%-0.1-62.07%-0.470.00%-0.1-37.50%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Alibaba
BABA
+4.34%
Micron Technology
MU
+4.04%
NVIDIA
NVDA
+2.63%
Cisco
CSCO
+1.61%
Netflix
NFLX
+1.43%

Unlock the Full List